Amgen files quarterly report (10-Q) for the period ended Mar 31, 2026

Amgen filed its quarterly report on Form 10-Q with the SEC on Apr 30, 2026, 7:04 PM ET, covering the quarter ended Mar 31, 2026. It reports fiscal Q1 2026 results.

• Revenue: $8.62B (+5.8% from $8.15B a year earlier)
• Operating income: $2.67B (+126.3% from $1.18B a year earlier)
• Net income: $1.82B (+5.1% from $1.73B a year earlier)
• Diluted EPS: $3.34 (+4.4% from $3.20 a year earlier)
• Form 10-Q accepted by EDGAR Apr 30, 2026, 7:04 PM ET
• Accession number 0000318154-26-000057

SEC filing 10-Q · accession 0000318154-26-000057 · sec.gov ↗